Continue to site >
Trending ETFs

Johnson & Johnson

Stock (NYSE)
JNJ
Payout Change
Pending
Price as of:
$155.4 +0.88 +0%
Dividend (Fwd)
$4.96
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
3.19%
JNJ: NYSE (Stock)

Johnson & Johnson

Payout Change
Pending
Price as of:
$155.4 +0.88 +0%
Dividend (Fwd)
$4.96
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
3.19%
JNJ: NYSE (Stock)

Johnson & Johnson

$155.4 +0%
Dividend (Fwd)
$4.96
Yield (Fwd)
Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.
3.19%
Payout Change
Pending
Analysis

Name

As of 11/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Johnson & Johnson

JNJ | stock

$155.40

0.57%

$374 B

3.19%

$4.96

-

Dividend Data
Stock Data
Avg Price Recovery
10.7 Days
Best dividend capture stocks in Nov
Payout Ratio (FWD)
Fwd Payout Ratio is used to examine if a company’s earnings can support the current dividend payment amount. It divides the Forward Annualized Dividend by FY1 EPS. Click here to learn more.
46.86%
Years of Dividend Increase
Consecutive Years of Dividend Increase is the number of years in a row in which there has been at least one payout increase and no payout decreases.
63 yrs
Dividend Frequency
Quarterly
Health Care Avg Yield
1.58%
5 best health care dividend stocks
Market Cap
$374.385 B
Day’s Range
$154.6 - $156.63
Volume
4,135,826
52 Wk Low/High
$143.13 - $168.85
Percent off 52 Wk High
-7.97%
FY1 PE
14.68x
FY1 EPS / Growth
$10.59 / 6.37%

Name

As of 11/27/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

  & DIV

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

Johnson & Johnson

JNJ | stock

$155.40

0.57%

$374 B

3.19%

$4.96

-

Ratings - JNJ

Dividend Safety

A+

63 years of consecutive dividend increase.

Yield Attractiveness

A

3.21% forward dividend yield. Top 30%.

Returns Risk

A+

0.5 beta (5Y monthly). Diversifier.

Returns Potential

A

15% price target upside from sell-side analysts. Top 40%.

Quant Recommendation - JNJ

Maximize Income Goal

Target

Yields of 7-9%

Horizon

Short

Risk

Moderate-to-high

Retirement Income Goal

Target

Blend low volatility & yield

Horizon

Long

Risk

Low

Monthly Income Goal

Regular payouts for JNJ are paid quarterly. Recommendation not provided. See Best Monthly Dividend Stocks Model Portfolio for our top monthly income ideas.

Growth Goal

Target

Market-beating returns

Horizon

Long

Risk

Moderate

Income & Growth Goal

Target

Blend yield & returns

Horizon

Moderate

Risk

Moderate

Sector Income & Growth Goal

Target

Blend yield & returns in the Health Care sector

Horizon

Long

Risk

Moderate-to-high

JNJ Payout History (Paid, Declared and Estimated)

Declared
Paid
Estimated
Year Calendar Year Payout (USD) Calendar Year Payout Growth (USD) Pay Date Declared Date Ex-dividend Date Payout Amount (USD) Qualified Dividend? Payout Type Frequency Days Taken For Stock Price To Recover Yield on Cost
2026e - -
2026-12-04
2026-10-19 2026-11-20 $1.2400 Qualified Regular Quarterly - -
2026-09-07
2026-07-20 2026-08-25 $1.2400 Qualified Regular Quarterly - -
2026-06-05
2026-04-17 2026-05-22 $1.2400 Qualified Regular Quarterly - -
2026-03-06
2026-01-02 2026-02-17 $1.2400 Qualified Regular Quarterly - -
2025e - -
2025-12-05
2025-10-17 2025-11-20 $1.2400 Qualified Regular Quarterly - -
2025-09-05
2025-07-18 2025-08-25 $1.2400 Qualified Regular Quarterly - -
2025-06-06
2025-04-18 2025-05-22 $1.2400 Qualified Regular Quarterly - -
2025-03-07
2025-01-03 2025-02-17 $1.2400 Qualified Regular Quarterly - -
2024e - -
2024-12-10
2024-10-15 2024-11-26 $1.2400 Qualified Regular Quarterly - 0.80%
2024-09-10
2024-07-17 2024-08-27 $1.2400 Qualified Regular Quarterly - 0.76%
2024-06-04
2024-04-16 2024-05-20 $1.2400 Qualified Regular Quarterly - 0.82%
2024-03-05
2024-01-02 2024-02-16 $1.1900 Qualified Regular Quarterly - 0.76%

JNJ Dividend Growth CAGR

Dividend Capture Strategy for JNJ

Dividend capture strategy is based on JNJ’s historical data. Past performance is no guarantee of future results.

Step 1: Buy JNJ shares 1 day before the ex-dividend date

Purchase Date

Feb 16, 2025

Upcoming Ex-Dividend Date

Feb 17, 2025

Step 2: SEll JNJ shares when price recovers

Sell Date (Estimate)

Feb 28, 2025

Avg Price Recovery

10.7 Days

Avg yield on cost

0.59%

See Full History

News & Research

News

Research

Company Profile

Company Overview

Exchanges: NYSE

Sector: Health Care

Industry: Biotech Pharma

No company description available.

Related Companies

Company Name

Price

Change

% Change

AVADEL PHARMACEUTICALS PLC

$11.17

$0.02

0.179%

Belite Bio Inc - ADR

$67.44

$3.42

5.342%

BioXcel Therapeutics, Inc.

$0.45

-$0.01

-2.174%

Bon Natural Life Ltd

$1.85

-$0.03

-1.596%

BioNeutra Global Corp

$0.07

$0.00

0.000%

BICO Group AB - ADR

$0.88

$0.00

0.000%

Chanticleer Holdings Inc

$8.76

-$1.67

-16.012%

BIOSTAX CORP

$0.03

$0.00

0.000%

Blueberries Medical Corp

$0.01

$0.00

0.000%

BC Bud Corporation (The)

$0.05

$0.00

0.000%

© 2020&nbsp Market data provided is at least 15-minutes delayed and hosted by Barchart Solutions.

Information is provided ‘as is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use, please see disclaimer